STRO-001

· Sutro Biopharma, Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for STRO-001, covering 2024-06-11 to 2024-06-11. Get the full timeline:

Most recent: Clinical Trial Update: Study of STRO-001, an Anti-CD74 Antibody Drug Conjugate, in Patients With Advanced B-Cell Malignancies [Phase 1]